Literature DB >> 20304284

Neck restaging with sentinel node biopsy in T1-T2N0 oral and oropharyngeal cancer: Why and how?

Vincent Burcia1, Valérie Costes, Jean Luc Faillie, Quentin Gardiner, Delphine de Verbizier, César Cartier, Elham Jouzdani, Louis Crampette, Bernard Guerrier, Renaud Garrel.   

Abstract

OBJECTIVE: To evaluate the lack of accuracy in neck staging with the classical technique (i.e., neck dissection and routine histopathology) with the sentinel node (SN) biopsy in oral and oropharyngeal T1-T2N0 cancer. STUDY
DESIGN: Cross-sectional study with planned data collection.
SETTING: Tertiary center care. SUBJECTS AND METHODS: In 50 consecutive patients, the pathological stage of sentinel node (pSN) was established after analyzing SN biopsies (n = 148) using serial sectioning and immunohistochemistry. Systematic selective neck dissection was performed. The pN stage was established with routine histopathologic analysis of both the non-SN (n = 1075) and the 148 SN biopsies.
RESULTS: The sensitivity and negative predictive value of pSN staging were 100 percent. Conversely, if one considers pSN staging procedure as the reference test for micro- and macro-metastasis diagnosis, the sensitivity of the classical pN staging procedure was 50 percent (9/1; 95% CI 26.9-73.1) and its negative predictive value was 78 percent (95% CI 61.9-88.8). Fifteen patients (30%) were upstaged, including nine cases from pN0 to pSN >or= 1 and six cases from pN1 to pSN2. Two of the pN0-pSN1 upstaged patients died with relapsed neck disease.
CONCLUSION: The SN biopsy technique appeared to be the best staging method in cN0 patients and provided evidence that routinely undiagnosed lymph node invasion may have clinical significance. Copyright 2010 American Academy of Otolaryngology-Head and Neck Surgery Foundation. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20304284     DOI: 10.1016/j.otohns.2009.12.016

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

Review 1.  Minimally invasive techniques for head and neck malignancies: current indications, outcomes and future directions.

Authors:  Dana M Hartl; Alfio Ferlito; Carl E Silver; Robert P Takes; Sandro J Stoeckli; Carlos Suárez; Juan P Rodrigo; Andreas M Sesterhenn; Carl H Snyderman; David J Terris; Eric M Genden; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-05-12       Impact factor: 2.503

Review 2.  Sentinel lymph node biopsy for oral cancer: supporting evidence and recent novel developments.

Authors:  Marcus M Monroe; Stephen Y Lai
Journal:  Curr Oncol Rep       Date:  2014-05       Impact factor: 5.075

3.  Near-infrared fluorescence sentinel lymph node mapping of the oral cavity in head and neck cancer patients.

Authors:  Joost R van der Vorst; Boudewijn E Schaafsma; Floris P R Verbeek; Stijn Keereweer; Jeroen C Jansen; Lilly-Ann van der Velden; Antonius P M Langeveld; Merlijn Hutteman; Clemens W G M Löwik; Cornelis J H van de Velde; John V Frangioni; Alexander L Vahrmeijer
Journal:  Oral Oncol       Date:  2012-08-28       Impact factor: 5.337

4.  Cytokeratin immunohistochemically detected nodal micrometastases in N0 laryngeal cancer: impact on the overall occult metastases.

Authors:  Hesham Negm; Mohamed Mosleh; Hesham Fathy; Amal Hareedy; Ahmad Elbattawy
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-05       Impact factor: 2.503

5.  The first and second echelon sentinel lymph node evaluation in oral cancer.

Authors:  Kuldeep Kumar Bassi; Anurag Srivastava; Vuthaluru Seenu; Rakesh Kumar; Rajinder Parshad; Sunil Chumber; Siddarth Datta Gupta; Sudhir Bahadur
Journal:  Indian J Surg       Date:  2012-06-02       Impact factor: 0.656

6.  Diagnostic value of sentinel lymph node biopsy in head and neck cancer: a meta-analysis.

Authors:  C F Thompson; M A St John; G Lawson; T Grogan; D Elashoff; A H Mendelsohn
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-22       Impact factor: 2.503

7.  Phototheranostic Porphyrin Nanoparticles Enable Visualization and Targeted Treatment of Head and Neck Cancer in Clinically Relevant Models.

Authors:  Nidal Muhanna; Cheng S Jin; Elizabeth Huynh; Harley Chan; Yi Qiu; Wenlei Jiang; Liyang Cui; Laura Burgess; Margarete K Akens; Juan Chen; Jonathan C Irish; Gang Zheng
Journal:  Theranostics       Date:  2015-10-18       Impact factor: 11.556

8.  Focus issue: neck dissection for oropharyngeal squamous cell carcinoma.

Authors:  Kathryn M Van Abel; Eric J Moore
Journal:  ISRN Surg       Date:  2012-01-15

9.  Additional non-sentinel lymph node metastases in early oral cancer patients with positive sentinel lymph nodes.

Authors:  Inne J Den Toom; Elisabeth Bloemena; Stijn van Weert; K Hakki Karagozoglu; Otto S Hoekstra; Remco de Bree
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-25       Impact factor: 2.503

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.